Effects of infection with entamoeba histolytica on blood parameters in cancer patients (Malignancy and leukaemia)
International Journal of Pharmaceutical Research, ISSN: 0975-2366, Vol: 12, Issue: sp2, Page: 1261-1264
2020
- 3Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures3
- Readers3
Article Description
Cancer and cancer therapy result in complications that reduce the ability of the immune system to resist infections. The present study was conducted in patients with malignant cancer and leukaemia from Basrah specialist children's hospital auditors of children infected with E. histolytica. Total white blood cell (WBC) count, haemoglobin (Hb) concentration, packed cell volume (PCV) and platelet (thrombocyte) count were examined; these parameters were shown to be lower in patients with cancer than in those infected with E. histolytica and healthy children. Patients with cancer had chronic or repeated infections with E. histolytica. Reduction in WBC count, Hb concentration, PCV and thrombocyte count in patients with cancer, particularly leukaemia, was a result of cancer and chemotherapy side effects that results in severe deficiencies in blood parameters of the treated patients with cancer.
Bibliographic Details
SynthesisHub Advance Scientific Research
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know